ABC
docz
Explore
Log in
Create new account
Download
Report
health and fitness
disease
cancer
Prognostic Markers and Mechanisms of Chemotherapy Resistance
KPTI Pipeline: Selinexor (KPT-330) & Oncology Drug Development
XPO1 is a rational target for double and triple-hit aggressive B
Guidelines for the Treatment of Diffuse Large B Cell Lymphoma (DLBCL)
Clinical Cancer Research Highlights of This Issue 5145 SPECIAL FEATURES CCR Translations
Are CAR T-Cells the Solution for Chemotherapy Refractory Diffuse
What is hot in lymphoma? News
Preclinical activity in non-Hodgkin`s lymphoma of selinexor, a
13 11 20 Call us What is cancer?
––– 2014 ANNUAL GALA –––
비·부비동에 발생한 미만성 거대 B세포 림프종 2예
© Copyright 2026
About abcdocz
DMCA / GDPR
Report
